Effect	effect	O	O
of	of	O	O
lindane	lindane	S_chemicals	O
on	on	O	O
hepatic	hepatic	O	O
and	and	O	O
brain	brain	O	O
cytochrome	cytochrome	S_chemicals	O
P450s	p450s	O	O
and	and	O	O
influence	influence	O	O
of	of	O	O
P450	p450	S_chemicals	O
modulation	modulation	O	O
in	in	O	O
lindane	lindane	S_chemicals	O
induced	induced	O	O
neurotoxicity	neurotoxicity	O	S_disease
.	.	O	O

Oral	oral	O	O
administration	administration	O	O
of	of	O	O
lindane	lindane	S_chemicals	O
(	(	O	O
2.5	2.5	O	O
,	,	O	O
5	5	O	O
,	,	O	O
10	10	O	O
and	and	O	O
15	15	O	O
mg/kg	mg/kg	O	O
,	,	O	O
body	body	O	B_disease
weight	weight	O	I_disease
)	)	O	O
for	for	O	O
5	5	O	O
days	days	O	O
was	was	O	O
found	found	O	O
to	to	O	O
produce	produce	O	O
a	a	O	O
dose-dependent	dose-dependent	O	O
increase	increase	O	O
in	in	O	O
the	the	O	O
activity	activity	O	O
of	of	O	O
P450	p450	S_chemicals	O
dependent	dependent	O	O
7-ethoxyresorufin-O-deethylase	7-ethoxyresorufin-o-deethylase	O	O
(	(	O	O
EROD	erod	S_chemicals	O
)	)	O	O
,	,	O	O
7-pentoxyresorufin-O-dealkylase	7-pentoxyresorufin-o-dealkylase	O	O
(	(	O	O
PROD	prod	S_chemicals	O
)	)	O	O
and	and	O	O
N-nitrosodimethylamine	n-nitrosodimethylamine	B_chemicals	O
demethylase	demethylase	S_chemicals	O
(	(	O	O
NDMA-d	ndma-d	O	O
)	)	O	O
in	in	O	O
rat	rat	O	O
brain	brain	O	O
and	and	O	O
liver	liver	O	O
.	.	O	O

A	a	O	O
significant	significant	O	O
increase	increase	O	O
in	in	O	O
the	the	O	O
hepatic	hepatic	O	O
and	and	O	O
brain	brain	O	O
P450	p450	S_chemicals	O
monooxygenases	monooxygenases	S_chemicals	O
was	was	O	O
also	also	O	O
observed	observed	O	O
when	when	O	O
the	the	O	O
duration	duration	O	O
of	of	O	O
exposure	exposure	O	O
of	of	O	O
low	low	B_chemicals	O
dose	dose	I_chemicals	O
(	(	O	O
2.5	2.5	O	O
mg/kg	mg/kg	O	O
)	)	O	O
of	of	O	O
lindane	lindane	S_chemicals	O
was	was	O	O
increased	increased	O	O
from	from	O	O
5	5	O	O
days	days	O	O
to	to	O	O
15	15	O	O
or	or	O	O
21	21	O	O
days	days	O	O
.	.	O	O

As	as	O	O
observed	observed	O	O
with	with	O	O
different	different	O	O
doses	doses	O	O
,	,	O	O
the	the	O	O
magnitude	magnitude	O	O
of	of	O	O
induction	induction	O	O
in	in	O	O
the	the	O	O
activity	activity	O	O
of	of	O	O
P450	p450	S_chemicals	O
monooxygenases	monooxygenases	S_chemicals	O
was	was	O	O
several	several	O	O
fold	fold	O	O
higher	higher	O	O
in	in	O	O
liver	liver	O	O
microsomes	microsomes	O	O
when	when	O	O
compared	compared	O	O
with	with	O	O
the	the	O	O
brain	brain	O	O
.	.	O	O

Western	western	O	O
blotting	blotting	O	O
studies	studies	O	O
have	have	O	O
indicated	indicated	O	O
that	that	O	O
the	the	O	O
increase	increase	O	O
in	in	O	O
the	the	O	O
P450	p450	B_chemicals	O
enzymes	enzymes	S_chemicals	O
could	could	O	O
be	be	O	O
due	due	O	O
to	to	O	O
the	the	O	O
increase	increase	O	O
in	in	O	O
the	the	O	O
expression	expression	O	O
of	of	O	O
P450	p450	S_chemicals	O
1A1/1A2	1a1/1a2	O	O
,	,	O	O
2B1/2B2	2b1/2b2	O	O
and	and	O	O
2E1	2e1	O	O
isoenzymes	isoenzymes	S_chemicals	O
.	.	O	O

In	in	O	O
vitro	vitro	O	O
studies	studies	O	O
using	using	O	O
organic	organic	O	O
inhibitors	inhibitors	O	O
specific	specific	O	O
for	for	O	O
individual	individual	O	O
P450	p450	S_chemicals	O
isoenzymes	isoenzymes	S_chemicals	O
and	and	O	O
antibody	antibody	O	O
inhibition	inhibition	O	O
experiments	experiments	O	O
have	have	O	O
further	further	O	O
demonstrated	demonstrated	O	O
that	that	O	O
the	the	O	O
increase	increase	O	O
in	in	O	O
the	the	O	O
activity	activity	O	O
of	of	O	O
PROD	prod	S_chemicals	O
,	,	O	O
EROD	erod	S_chemicals	O
and	and	O	O
NDMA-d	ndma-d	O	O
are	are	O	O
due	due	O	O
to	to	O	O
the	the	O	O
increase	increase	O	O
in	in	O	O
the	the	O	O
levels	levels	O	O
of	of	O	O
P450	p450	S_chemicals	O
2B1/2B2	2b1/2b2	O	O
,	,	O	O
1A1/1A2	1a1/1a2	O	O
and	and	O	O
2E1	2e1	O	O
isoenzymes	isoenzymes	S_chemicals	O
,	,	O	O
respectively	respectively	O	O
.	.	O	O

Induction	induction	O	O
studies	studies	O	O
have	have	O	O
further	further	O	O
shown	shown	O	O
that	that	O	O
while	while	O	O
pretreatment	pretreatment	O	O
of	of	O	O
3-methylcholanthrene	3-methylcholanthrene	O	O
(	(	O	O
MC	mc	O	O
)	)	O	O
,	,	O	O
an	an	O	O
inducer	inducer	S_chemicals	O
of	of	O	O
P4501A1/1A2	p4501a1/1a2	O	O
,	,	O	O
did	did	O	O
not	not	O	O
produce	produce	O	O
any	any	O	O
significant	significant	O	O
effect	effect	O	O
in	in	O	O
the	the	O	O
incidence	incidence	O	O
of	of	O	O
lindane	lindane	S_chemicals	O
induced	induced	O	O
convulsions	convulsions	O	S_disease
,	,	O	O
pretreatment	pretreatment	O	O
with	with	O	O
phenobarbital	phenobarbital	S_chemicals	O
(	(	O	O
PB	pb	O	O
)	)	O	O
,	,	O	O
an	an	O	O
inducer	inducer	S_chemicals	O
of	of	O	O
P450	p450	S_chemicals	O
2B1/2B2	2b1/2b2	O	O
or	or	O	O
ethanol	ethanol	S_chemicals	O
,	,	O	O
an	an	O	O
inducer	inducer	S_chemicals	O
of	of	O	O
P450	p450	S_chemicals	O
2E1	2e1	O	O
catalysed	catalysed	O	O
reactions	reactions	O	O
,	,	O	O
significantly	significantly	O	O
increased	increased	O	O
the	the	O	O
incidence	incidence	O	O
of	of	O	O
lindane	lindane	S_chemicals	O
induced	induced	O	O
convulsions	convulsions	O	S_disease
.	.	O	O

Similarly	similarly	O	O
,	,	O	O
when	when	O	O
the	the	O	O
P450-mediated	p450-mediated	O	O
metabolism	metabolism	O	O
of	of	O	O
lindane	lindane	S_chemicals	O
was	was	O	O
blocked	blocked	O	O
by	by	O	O
cobalt	cobalt	S_chemicals	O
chloride	chloride	S_chemicals	O
incidence	incidence	O	O
of	of	O	O
convulsions	convulsions	O	S_disease
was	was	O	O
increased	increased	O	O
in	in	O	O
animals	animals	O	O
treated	treated	O	O
with	with	O	O
lindane	lindane	S_chemicals	O
indicating	indicating	O	O
that	that	O	O
lindane	lindane	S_chemicals	O
per	per	O	O
se	se	O	O
or	or	O	O
its	its	O	O
metabolites	metabolites	O	O
formed	formed	O	O
by	by	O	O
PB	pb	O	O
or	or	O	O
ethanol	ethanol	S_chemicals	O
inducible	inducible	S_chemicals	O
P450	p450	S_chemicals	O
isoenzymes	isoenzymes	S_chemicals	O
are	are	O	O
involved	involved	O	O
in	in	O	O
its	its	O	O
neurobehavioral	neurobehavioral	O	S_disease
toxicity	toxicity	O	O
.	.	O	O

